In lupus disease, loss or blockade of cognate B-T cell interactions involving CD40-CD40L ameliorates disease and prolongs survival in the NZB/NZW F1 and MRL-lpr spontaneous models of lupus [240–242]. This evidence concerns the gene CD40LG and systemic lupus erythematosus.